FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, microbiology, veterinary medicine, namely to a method for ozonation of physiological solution. Method for ozonation of physiological solution, comprising connecting an ozone generator to an electrical network, inserting a long needle into the cork, reaching the bottom of the bottle, and a short needle not reaching the surface of the solution, polyvinyl chloride tube is connected to the long needle from the outlet of the apparatus, switching on the apparatus and performing bubbling, characterized by that ozone concentration at the outlet of the ozoniser is from 4 to 5 mg/l, the ozone-oxygen mixture is introduced into 400 ml of physiological solution, bubbling is carried out at room temperature for 15–20 minutes.
EFFECT: said invention enables long-term preservation of ozone concentration and its bactericidal activity in physiological solution.
1 cl, 2 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OZONIZING OF PHYSIOLOGICAL SALT SOLUTION | 2004 |
|
RU2289413C2 |
METHOD OF TREATING STAPHYLOCOCCUS AUREUS CULTURE WITH OXYGEN-CONTAINING GAS FROM PORTABLE OZONISER | 2018 |
|
RU2709720C1 |
METHOD FOR PERFTORAN OZONATION | 2009 |
|
RU2445076C2 |
DEVICE FOR INTRAVENOUS INFUSIONS IN OZONE THERAPY | 2021 |
|
RU2758124C1 |
TREATMENT METHOD OF PURULENT-NECROTIC WOUNDS | 2019 |
|
RU2727867C1 |
CONCENTRATED SOLUTION OF STABILISED OZONE FOR TREATMENT OF INFLAMMATORY PROCESSES | 2006 |
|
RU2324468C2 |
METHOD OF TREATING SUPPURATIVE SEPTIC COMPLICATIONS OF PROSTATE ADENOMA | 2011 |
|
RU2481847C2 |
METHOD FOR INTRAPORTAL OZONE THERAPY IN PATIENTS WITH WIDESPREAD PERITONITIS | 2015 |
|
RU2594512C1 |
METHOD FOR SUPPRESSING HIV-INFECTION | 1999 |
|
RU2198664C2 |
METHOD FOR TREATING THE CASES OF FOCAL FORMATIONS IN THE THYROID GLAND | 2002 |
|
RU2221572C1 |
Authors
Dates
2024-02-28—Published
2023-08-01—Filed